| Nintedanib studied in …STUDIED_INderived71 of 71show fewer |
|---|
| → studied in | NCT01658462Phase 2 · completed Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer · 71 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377023Phase 1/Phase 2 · active not recruiting Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856425Phase 1 · completed Trial Of Pembrolizumab And Nintedanib · 71 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03513484Phase 1 · active not recruiting Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia · 71 trials list this drug (2 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02863055Phase 2 · terminated Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma · 71 trials list this drug (2 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299141Phase 2 · completed Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496585Phase 2 · completed Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis · 71 trials list this drug (2 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02231164Phase 3 · terminated LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01346540Phase 1 · completed A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology. · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02300298Phase 1 · completed Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780700Phase 2 · terminated Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2] · 71 trials list this drug (2 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182245Phase 1 · completed Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies · 71 trials list this drug (2 active) | — | — | Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182219Phase 1 · completed Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer · 71 trials list this drug (2 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009579Phase 2 · completed ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer · 71 trials list this drug (2 active) | — | — | Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02902484Phase 1/Phase 2 · terminated Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer · 71 trials list this drug (2 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02225405Phase 1 · completed Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399215Phase 2 · completed Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · 71 trials list this drug (2 active) | — | — | Neuroendocrine Neoplasm,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01583322Phase 2 · completed Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03062943Phase 2 · completed A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) · 71 trials list this drug (2 active) | — | — | Lymphangioleiomyomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03287947Phase 2 · terminated LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma · 71 trials list this drug (2 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03292250Phase 2 · completed Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] · 71 trials list this drug (2 active) | — | — | Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01485874Phase 1 · terminated Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568449Phase 2 · completed Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent · 71 trials list this drug (2 active) | — | — | Pleural Mesothelial Neoplasm,Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02808247Phase 2 · terminated Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma · 71 trials list this drug (2 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02531737Phase 2 · completed Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01024920Phase 2 · completed Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib. · 71 trials list this drug (2 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393755Phase 1/Phase 2 · completed Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer · 71 trials list this drug (2 active) | — | — | Colon Adenocarcinoma,Colon Carcinoma,Malignant Colon Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02668393Phase 1 · completed Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234596Phase 2 · completed Nintedanib in Patients With Advanced Esophagogastric Cancer · 71 trials list this drug (2 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361319Phase 1/Phase 2 · withdrawn Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02308553Phase 1/Phase 2 · completed Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma · 71 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01788982Phase 2 · completed Nintedanib(BIBF1120) in Thyroid Cancer · 71 trials list this drug (2 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02452463Phase 2 · terminated Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619162Phase 1 · completed Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics · 71 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389764Phase 2 · terminated Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) · 71 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01610869Phase 2 · completed Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01907100Phase 2/Phase 3 · terminated Nintedanib (BIBF 1120) in Mesothelioma · 71 trials list this drug (2 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02751385Phase 1 · terminated Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01669798Phase 2 · completed BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01022853Phase 1 · completed Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02835833Phase 1 · completed Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors · 71 trials list this drug (2 active) | — | — | Cervical Carcinoma,Colorectal Adenocarcinoma,Lung Non-Squamous Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01015118Phase 3 · completed LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Peritoneal Neoplasm,Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01666600Phase 1/Phase 2 · terminated NOA-12: BIBF1120 and R-RT in Glioblastoma · 71 trials list this drug (2 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004003Phase 2 · completed Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma · 71 trials list this drug (2 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01225887Phase 2 · completed Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer · 71 trials list this drug (2 active) | — | — | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,Endometrial Adenocarcinoma,Endometrial Mucinous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441297Phase 2 · completed BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02149108Phase 3 · completed Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1) · 71 trials list this drug (2 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01948141Phase 2 · completed Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856867Phase 2 · withdrawn Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) · 71 trials list this drug (2 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00806819Phase 3 · completed Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00710762Phase 2 · completed A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer · 71 trials list this drug (2 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02866370Phase 2 · unknown Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium · 71 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02152059Phase 2 · withdrawn A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy · 71 trials list this drug (2 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987935Phase 2 · completed A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients · 71 trials list this drug (2 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01594125Phase 1 · completed Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma · 71 trials list this drug (2 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01684111Phase 1 · completed An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1) · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02558387Phase 2 · unknown Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck · 71 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00998296Phase 1 · completed Phase I Dose Escalation Study of Concomitant BIBF 1120 and BIBW 2992 in Patients With Advanced Solid Tumours. · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278978Phase 2 · unknown BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma · 71 trials list this drug (2 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00904839Phase 2 · completed BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer · 71 trials list this drug (2 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01683682Phase 1 · completed An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00706628Phase 2 · completed A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer · 71 trials list this drug (2 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715403Phase 1 · completed A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01380782Phase 2 · completed BIBF 1120 for Recurrent High-Grade Gliomas · 71 trials list this drug (2 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligoastrocytoma,Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182102Phase 1 · completed Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182128Phase 1 · completed A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182206Phase 1 · completed An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02182232Phase 1 · completed A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer · 71 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01951846Phase 1 · completed To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours · 71 trials list this drug (2 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01251484Phase 2 · completed BIBF 1120 in Recurrent Glioblastoma Multiforme · 71 trials list this drug (2 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00730821Phase 1 · completed Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid Tumors · 71 trials list this drug (2 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |